Form 4: Myriad Genetics SVP Margaret Ancona Reports Stock Transaction
SEC Form 4 Filing
Margaret Ancona, SVP and Chief of Staff at Myriad Genetics, reports the disposal of 2,697 shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 25, 2025, Margaret Ancona, SVP and Chief of Staff of Myriad Genetics Inc., disposed of 2,697 shares of common stock.
- The transaction was to cover tax withholding obligations related to the vesting of restricted stock units.
- The shares were disposed of at a price of $11.74 per share.
- Following the transaction, Ancona directly owns 75,703 shares of Myriad Genetics Inc.
- The transaction was reported on February 26, 2025.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so it doesn't significantly impact the overall sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for investors to monitor.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/25/2025 | Date of stock transaction (disposal of shares). |
| 02/26/2025 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.